MI Sign Up for eTOC Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimple, R. J.
Right arrow Articles by Siderovski, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimple, R. J.
Right arrow Articles by Siderovski, D. P.
Molecular Interventions 2:88-100 (2002)
© 2002 American Society of Pharmacology and Experimental Therapeutics


Review

The GoLoco Motif: Heralding a New Tango Between G Protein Signaling and Cell Division

Randall J. Kimple, Francis S. Willard and David P. Siderovski

Department of Pharmacology Lineberger Comprehensive Cancer Center Unc Neuroscience Center The University of North Carolina at Chapel Hill Chapel Hill NC 27599-7365 USA

Correspondence: DPS. E-mail dsiderov{at}med.unc.edu; fax 919-966-5640.


Heterotrimeric G proteins regulate signaling pathways downstream of plasma membrane-bound receptors. Several mechanisms have been discovered that promote the separate effector functions of the G{alpha} and the Gß{gamma} subunits. Recent efforts have identified GoLoco motif-containing proteins as G{alpha}-associated proteins that can regulate the reassociation of G{alpha} to Gß{gamma}, and that might effect signal transduction on their own. In what physiological processes are these proteins involved?

The G{alpha} and Gß{gamma} components of heterotrimeric G proteins, typically associated with cell-surface receptor signaling, also partake in the macromolecular interactions that underlie cell polarity and cell division. Proteins with G{alpha}-binding GoLoco motifs, such as Drosophila melanogaster Pins (for Partner of Inscuteable) and its mammalian counterpart LGN, participate in multi-protein complexes that maintain cellular asymmetry and orderly segregation of chromosomal content and daughter cell bodies. The GoLoco motif was recently identified as a selective G{alpha}-binding partner: the GoLoco–G{alpha} interaction can displace Gß{gamma} and inhibit guanine nucleotide release from the bound G{alpha} subunit. Recent x-ray crystallographic studies suggest ways in which GoLoco-motif peptides may modulate heterotrimeric G protein signaling. Such peptides could be exploited to help dissect the signals that underpin cell polarity and cell division processes.




This article has been cited by other articles:


Home page
Plant Cell PhysiolHome page
T. Suzuki, S. Nakajima, S. Inagaki, M. Hirano-Nakakita, K. Matsuoka, T. Demura, H. Fukuda, A. Morikami, and K. Nakamura
TONSOKU is Expressed in S Phase of the Cell Cycle and its Defect Delays Cell Cycle Progression in Arabidopsis
Plant Cell Physiol., May 1, 2005; 46(5): 736 - 742.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
K. S. Nair, A. Mendez, J. B. Blumer, D. H. Rosenzweig, and V. Z. Slepak
The Presence of a Leu-Gly-Asn Repeat-Enriched Protein (LGN), a Putative Binding Partner of Transducin, in ROD Photoreceptors
Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 383 - 389.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Obin, B. Y. Lee, G. Meinke, A. Bohm, R. H. Lee, R. Gaudet, J. A. Hopp, V. Y. Arshavsky, B. M. Willardson, and A. Taylor
Ubiquitylation of the Transducin beta gamma Subunit Complex. REGULATION BY PHOSDUCIN
J. Biol. Chem., November 8, 2002; 277(46): 44566 - 44575.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.